223 related articles for article (PubMed ID: 29709016)
1. EBV persistence without its EBNA3A and 3C oncogenes in vivo.
Murer A; McHugh D; Caduff N; Kalchschmidt J; Barros M; Zbinden A; Capaul R; Niedobitek G; Allday M; Chijioke O; Münz C
PLoS Pathog; 2018 Apr; 14(4):e1007039. PubMed ID: 29709016
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
Bazot Q; Paschos K; Allday MJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
[TBL] [Abstract][Full Text] [Related]
3. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
J Virol; 2020 May; 94(10):. PubMed ID: 32132242
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
6. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
[TBL] [Abstract][Full Text] [Related]
7. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
[TBL] [Abstract][Full Text] [Related]
8. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ
PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465
[TBL] [Abstract][Full Text] [Related]
9. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
[TBL] [Abstract][Full Text] [Related]
11. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells.
Allday MJ; Bazot Q; White RE
Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372
[TBL] [Abstract][Full Text] [Related]
12. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
[TBL] [Abstract][Full Text] [Related]
16. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
[TBL] [Abstract][Full Text] [Related]
17. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.
Bazot Q; Paschos K; Skalska L; Kalchschmidt JS; Parker GA; Allday MJ
PLoS Pathog; 2015 Jul; 11(7):e1005031. PubMed ID: 26153983
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9.
Harth-Hertle ML; Scholz BA; Erhard F; Glaser LV; Dölken L; Zimmer R; Kempkes B
PLoS Pathog; 2013 Sep; 9(9):e1003638. PubMed ID: 24068939
[TBL] [Abstract][Full Text] [Related]
20. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.
Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV
J Virol; 2004 Dec; 78(24):13891-900. PubMed ID: 15564497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]